XDA Developers on MSN

This open-source PDF viewer is better than Adobe Acrobat for research papers and textbooks

If you're on the hunt for a lightweight, open-source PDF app with a strong developer backing and perfect for navigating ...

I tested 5 open-source document scanners for Android so you don’t have to

Discover five top open source Android document scanners that offer privacy, ease, and great features without ads or trackers.

I used ChatGPT to make sense of my employee benefits — here’s how it saved my open enrollment

Open enrollment can be overwhelming. I used ChatGPT to analyze health plans, compare benefits and explain confusing terms — ...

Did Epstein really own a painting of Bill Clinton in a blue dress? Investigating the rumor

After the U.S. Congress voted to release all of the files connected to the late, convicted sex offender Jeffrey Epstein's ...

Rumor has it Epstein owned a painting of Bill Clinton in a blue dress. We investigated

After the U.S. Congress voted to release all of the files connected to the late, convicted sex offender Jeffrey Epstein's ...

The Pixel 10 Pro Fold just replaced half my tech setup and fits in my pocket

If you’re comfortable replacing other pieces of your tech daily carry, the Pixel 10 Pro Fold might actually wind up saving ...

5 everyday tasks that got simpler now that my ID lives in Samsung Wallet

The biggest advantage of storing your ID in Samsung Wallet is that you don't always need to carry a physical ID. It not only eliminates the fear of a stranger misusing it, but also mitigates the risk ...
The Hospitalist

Navigating the Path to Promotion

Navigating academic promotion for hospitalists involves understanding evolving criteria, institutional variations, and the ...
inews.co.uk

OBR chief quits over Budget leak

Watchdog said earlier today its leadership must take 'immediate steps to change completely' how it publishes twice-yearly reports containing sensitive forecasts ...
The Manila Times

Johnson & Johnson receives European Commission approval of IMAAVY® (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...